The national recommendation for the covid-19 prevention and control in pediatric units of hematology and oncology, hematopoietic cell transplantation units and respective outpatient clinics: Guidelines of polish society of pediatric oncology and hematology

In December 2019 novel coronavirus SARS-CoV-2 has been identified. It is responsible for a pandemic COVID-19 disease with a risk of fatal outcome ranging 2% to 6%. Pediatric patients with cancer during intensive oncological treatment are considered as a risk group of unfavorable outcomes because of profound immunosuppression. Based on literature and the national local experiences, the Polish Society of Pediatric Oncology and Hematology provided with the national recommendation for the COVID-19 prevention and control in pediatric hematology and oncology, hematopoietic cell transplantation units and well as respective outpatient clinics. Copyright © 2020, Wydawnictwo Czelej Sp. z o.o.. All rights reserved.